Medeon Biodesign, Inc. (TPEX:6499)

Medeon Biodesign Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	625.43	513.37	1,238	483.9	735.32	1,128
Short-Term Investments	308.25	652.18	862.1	1,025	1,608	1,058
Trading Asset Securities	41.32	41.66	41.93	37.87	6.48	-
Cash & Short-Term Investments	975	1,207	2,142	1,547	2,350	2,186
Cash Growth	-49.75%	-43.64%	38.44%	-34.16%	7.49%	21.44%
Accounts Receivable	66.1	37.84	41.77	32.35	10.12	164.81
Other Receivables	9.87	7.71	8.37	26.65	5.12	5.5
Receivables	75.97	45.55	50.15	59.01	15.25	170.31
Inventory	33.36	34.1	10.77	10.06	-	45.48
Prepaid Expenses	27.78	30.34	24.89	21.42	24.68	17.75
Total Current Assets	1,112	1,317	2,228	1,638	2,390	2,420
Property, Plant & Equipment	340.29	355.47	321.82	340.24	44.52	666.03
Long-Term Investments	-	-	-	1,876	1,847	-
Goodwill	159.28	106.74	106.74	106.74	39.23	72.19
Other Intangible Assets	-	55.01	64.33	73.44	39.71	141.33
Long-Term Deferred Tax Assets	32.95	32.95	-	-	-	4.12
Other Long-Term Assets	7.08	10.37	26.46	5.59	4.58	10.93
Total Assets	1,652	1,878	2,747	4,040	4,364	3,314
Accounts Payable	13.94	12	5.36	3.94	0.05	28.26
Accrued Expenses	-	113.03	98.01	73.09	68.33	73.19
Current Portion of Leases	52.2	54.56	47.15	36.69	14.53	23.53
Current Income Taxes Payable	-	-	37.97	56.78	66.74	41.75
Current Unearned Revenue	10.45	4.51	3.11	0.86	0.65	11.13
Other Current Liabilities	107.85	31.54	30.16	27.17	10	19.73
Total Current Liabilities	184.44	215.64	221.76	198.51	160.3	197.59
Long-Term Debt	-	-	-	-	-	12.94
Long-Term Leases	103.97	113.84	139.59	162.22	15.71	456.3
Long-Term Deferred Tax Liabilities	11.87	12.36	14.31	15.74	-	-
Total Liabilities	300.28	341.84	375.65	376.48	176	666.83
Common Stock	922.45	922.45	922.45	878.4	732.34	665.03
Additional Paid-In Capital	1,339	1,339	1,341	1,344	1,349	1,933
Retained Earnings	-975.16	-792.94	31.25	1,355	2,072	-525.91
Treasury Stock	-5.25	-5.25	-10.6	-10.6	-10.6	-20.48
Comprehensive Income & Other	62.27	56.73	36.18	30.94	-12.49	-6.68
Total Common Equity	1,344	1,520	2,320	3,597	4,130	2,045
Minority Interest	7.92	15.71	51.51	66.1	58.15	602.47
Shareholders' Equity	1,351	1,536	2,371	3,664	4,188	2,648
Total Liabilities & Equity	1,652	1,878	2,747	4,040	4,364	3,314
Total Debt	156.17	168.4	186.74	198.91	30.24	492.76
Net Cash (Debt)	818.83	1,039	1,955	1,348	2,320	1,693
Net Cash Growth	-52.86%	-46.87%	45.01%	-41.87%	36.98%	0.68%
Net Cash Per Share	8.88	11.27	21.24	14.65	25.19	18.48
Filing Date Shares Outstanding	92.22	92.14	92.04	92.02	92.02	91.63
Total Common Shares Outstanding	92.22	92.14	92.04	92.02	92.02	91.63
Working Capital	927.67	1,102	2,006	1,439	2,230	2,222
Book Value Per Share	14.57	16.50	25.21	39.10	44.89	22.32
Tangible Book Value	1,184	1,358	2,149	3,417	4,051	1,832
Tangible Book Value Per Share	12.84	14.74	23.35	37.14	44.03	19.99
Machinery	-	229.55	178.49	168.97	46.34	239.52
Leasehold Improvements	-	84.96	46.22	45.6	6.43	74.41

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.